The Netherlands certainly has a lot going for it when it comes to attracting the world’s leading biopharmaceutical companies: World-class research institutes, a well-respected healthcare system and not least of all the new home of the European Medicines Agency. FTI Consulting and IvCB explore whether there is another side to the story.
Please download the full article to read further.
